New Jersey-based Johnson & Johnson Consumer has entered into a definitive agreement to purchase US dermocosmetics company, NeoStrata.
The acquisition will include NeoStrata’s affiliates and its privately-held parent company TriStrata.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Johnson & Johnson Consumer worldwide chairman Jorge Mesquita said: "Doctors Ruey Yu and Eugene Van Scott formed NeoStrata in 1988 and continue to make significant contributions to the science of skincare.
"NeoStrata’s legacy in dermocosmetics will complement our global consumer portfolio and enable us to deliver advanced skincare brands to consumers around the world.
"NeoStrata and Johnson & Johnson share a strong history of innovation and together, we will work to discover important new skin care solutions grounded in deep human insights and compelling science.
"We look forward to working closely with NeoStrata’s distributors around the world and having their outstanding team of employees join Johnson & Johnson Consumer later this year."
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataExpected to close in the first half of this year, the acquisition is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions.
Financial terms of the transaction have not yet been disclosed.
Based in Princeton, New Jersey, NeoStrata has researched in Alpha hydroxy acids, which has become a standard among anti-aging technologies.
The company develops, as well as markets, a wide range of clinically-proven, dermatologist-developed, skincare products that can address the needs of every skin type.
